中国科技核心期刊
CN:31-1600/Q
ISSN:1004-0374
“健康与疾病的免疫”国际学术研讨会通知      关于有网站冒充本刊网站的声明
《生命科学》 2004, (5): 301-
基于酵母水平的高通量药物筛选
陈 晴, 李国伟, 杜 毅, 陈 静, 蒋华良, 沈 旭
中国科学院上海生命科学研究院药物研究所, 中国科学院研究生院, 上海 201203
摘 要:随着后基因组时代的到来,越来越多的药物靶标蛋白将会被发现,基于靶标蛋白设计出的化合物也将大量涌现,高通量药物筛选日趋重要。酵母基因组的易操作性及其简单稳定的培养条件,使得该真核微生物成为一种理想的药物筛选工程细胞。本文讨论了选择酵母系统进行细胞水平筛选的优缺点,并从基于靶点和表型两种筛选模式对酵母水平的高通量药物筛选做一总结。
关键词:酵母; 药物靶点; 高通量药物筛选; 细胞水平筛选
 
Yeast-based high-throughput drug screening
CHEN Qing, LI Guo-Wei, DU Yi, CHEN Jing, JIANG Hua-Liang, SHEN Xu
Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Graduate School of CAS, Shanghai 201203, China
Abstract: With the approaching of the post-genome era, more and more potential drug targets will be discovered, and the number of the designed compounds based on the targets is rapidly expanding. HTS (High Throughput Screening) technology is thus attracting  much attention. The characteristics of easy genetic manipulation and simple and steady culture conditions for yeast have made this eukaryotic microorganism an attractive option for drug screening. This article discusses the applicability and shortcomings of yeast-based drug screening, and gives a summary of yeast-based drug screening technique with focus on the target- and phenotype-based screening models.
Key words: yeast; drug-target; HTS; cell-based screening
 
首页 | 刊物简介 | 编委会 | 投稿须知 | 广告业务 | 过刊浏览 | 联系我们
中国科学院上海生命科学信息中心《生命科学》编辑部
Copyright © 2012-2015 《生命科学》编辑部 All Rights Reserved.
沪ICP备05033115号-30
您是第2955420 位访问者,欢迎!